Table 1. Description of female patients suffering from SLE included in the study.
| Patients | Age | SLEDAI | Treatment | Number of autophagic vacuoles counted for 50 T cells |
|---|---|---|---|---|
| 1 |
41 |
5 |
mycofenolate mofetyl |
14 |
| 2 |
33 |
4 |
mycofenolate mofetyl, prednisone |
30 |
| 3 |
27 |
2 |
prednisone, mycofenolate mofetyl |
1 |
| 4 |
52 |
14 |
hydroxychloroquine, mycofenolate mofetyl, prednisone |
5 |
| 5 |
30 |
4 |
hydroxychloroquine, AVK, prednisone |
10 |
| 6 |
33 |
0 |
none |
21 |
| 7 |
30 |
4 |
prednisone |
14 |
| 8 |
33 |
2 |
hydroxychloroquine, AVK |
18 |
| 9 |
44 |
4 |
mycofenolate mofetyl |
12 |
| 10 |
21 |
6 |
hydroxychloroquine, azathioprine, prednisone |
16 |
| 11 | 16 | 12 | mycofenolate mofetyl, prednisone | 36 |
SLEDAI (systemic lupus erythematous disease activity index) score, age and treatments for the patients studied. The number of autophagic vacuoles in T cells isolated from peripheral blood of these patients is also indicated. AVK = anti-vitamin K.